Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00272233 · ClinicalTrials.gov registry record
Effects of Sleep Loss on Endothelial Function and Cytokine Levels in Internal Medicine Residents
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 22
- Enrollment target
NCT00272233 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 22 participants.
The verdict
NCT00272233 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
Work requirements for medical trainees result in substantial sleep loss. Sleep loss has been associated with increased levels of certain inflammatory hormones that could have negative impact on blood vessel function. The purpose of this study is to determine the effects of sleep loss on blood hormone levels and blood vessel function in medical trainees.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2004-12 |
| Est. Completion | 2005-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00272233
The ClinicalTrials.gov registry entry for NCT00272233 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00272233 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00272233 about?
NCT00272233 is a clinical study titled "Effects of Sleep Loss on Endothelial Function and Cytokine Levels in Internal Medicine Residents". Work requirements for medical trainees result in substantial sleep loss. Sleep loss has been associated with increased levels of certain inflammatory hormones that could have negative impact on blood vessel function. The purpose of this study is to determine the effects of sleep loss on blood hormon...
What is the current status of trial NCT00272233?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2004-12. Estimated completion is 2005-06.
Who is sponsoring clinical trial NCT00272233?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.